(October 29, 2015, 9:53 AM EDT) -- WASHINGTON, D.C. — A medical device company consented to a jury deciding the issue of obviousness in a patent infringement lawsuit and, thus, cannot ask whether the “reason to combine” inquiry is a question of fact, subject to an appeal review on appeal, or a legal question for the court, and reviewed de novo, KFx Medical Corp. argues in an Oct. 9 brief to the U.S. Supreme Court (Arthrex, Inc. v. KFx Medical Corp., No. 15-291, U.S. Sup.)....